DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low - Time to Sell?

Key Points

• DENTSPLY SIRONA shares fell to a new 52-week low of $9.36, closing near $9.38 and well below its 50-day and 200-day moving averages.
• Analyst sentiment is mixed but leans toward “Hold,” with three Buy, nine Hold, and three Sell ratings; the consensus price target is $13.31, above the current share price.
• The company exceeded quarterly EPS and revenue estimates, but revenue declined 4.1% year over year and it reported a negative net margin. Institutional investors own 95.7% of the stock, with several major funds recently building positions.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) hit a new 52-week low on Friday . The company traded as low as $9.36 and last traded at $9.38, with a volume of 9306449 shares. The stock had previously closed at $10.14.

Analyst Upgrades and Downgrades

Several brokerages recently commented on XRAY. Barrington Research set a $15.00 price objective on shares of DENTSPLY SIRONA in a research report on Monday, August 10th. BMO Capital Markets dropped their target price on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating on the stock in a research report on Thursday. Barclays upped their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an "underweight" rating in a research note on Monday, August 24th. Piper Sandler lifted their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 29th. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Three investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $13.31.

DENTSPLY SIRONA Stock Performance

The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The stock has a market capitalization of $1.87 billion, a PE ratio of -3.41, a PEG ratio of 1.29 and a beta of 0.84. The firm has a 50 day moving average price of $11.96 and a 200-day moving average price of $11.51.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The firm had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. During the same quarter in the prior year, the firm earned $0.52 earnings per share. DENTSPLY SIRONA's revenue for the quarter was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. BlackRock Inc. acquired a new stake in DENTSPLY SIRONA during the second quarter worth about $283,405,000. Southpoint Capital Advisors LP acquired a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at about $116,000,000. Armistice Capital LLC grew its holdings in DENTSPLY SIRONA by 27.2% in the fourth quarter. Armistice Capital LLC now owns 7,298,000 shares of the medical instruments supplier's stock valued at $83,416,000 after purchasing an additional 1,562,000 shares during the period. Invenomic Capital Management LP increased its holdings in DENTSPLY SIRONA by 17.9% in the 4th quarter. Invenomic Capital Management LP now owns 5,132,036 shares of the medical instruments supplier's stock worth $58,659,000 after acquiring an additional 780,837 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. purchased a new stake in shares of DENTSPLY SIRONA during the second quarter worth about $47,780,000. Hedge funds and other institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.